![Srdjan Stankovic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Srdjan Stankovic
Plus aucun poste en cours
Profil
Le Dr Srdjan R. Stankovic, MD, est président d'ACADIA Pharmaceuticals, Inc. Il est membre du conseil d'administration de Neurogene, Inc. Le Dr. Stankovic a précédemment occupé les postes de SVP-Clinical Development & Medical Affairs chez Alkermes Plc, SVP & Head-Global Clinical Development chez Teva Pharmaceuticals USA, Inc. et SVP-Medical Affairs & Clinical Development chez Forest Laboratories, Inc, Chief Development Officer & EVP chez Neurogen Corp, Senior Vice President-Worldwide Clinical Research chez Cephalon, Inc, Vice President-US Clinical Development chez Johnson & Johnson Pharmaceutical Research & Development LLC, et Vice President-US Clinical Development chez UCB Pharma, Inc. Il a obtenu son diplôme d'études supérieures de l'Université d'Alabama et un doctorat de l'Université de Belgrade.
Anciens postes connus de Srdjan Stankovic
| Sociétés | Poste | Fin |
|---|---|---|
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Directeur/Membre du Conseil | 29/12/2023 |
| ACADIA PHARMACEUTICALS INC. | President | 31/12/2022 |
| ALKERMES PLC | Directeur Technique/Scientifique/R&D | 01/11/2015 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Corporate Officer/Principal | 01/01/2013 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01/06/2010 |
Formation de Srdjan Stankovic
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
The University of Alabama
 The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services | Commercial Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research, development & commercialisation of pharmeceutical and biotechnology products | Commercial Services |
University of Belgrade
 University of Belgrade Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Health Technology |
